Intellia Therapeutics IPO Info

Company Name: Intellia Therapeutics
Stock Symbol: NTLA
Exchange: NASDAQ
Status: Priced
IPO Date: 5/6/2016
IPO Price: 18.00 (-27.17%)

Underwriters

Credit Suisse, Jefferies LLC, and Leerink Partners

Amount of Offering: N/A
Number of Shares Offered: 6 Mil
Shares Outstanding After Offering: N/A
Valuation: N/A

Company Description

Intellia Therapeutics is a leading gene editing company focused on the development of proprietary and potentially curative therapeutics using CRISPR/Cas9 technology.

News Headlines

• Intellia Therapeutics (NTLA) IPO Opens 21% Higher
• Intellia Therapeutics (NTLA) IPO Set to Open After Pricing at $18